Febrile neutropenia due to COVID-19 in an immunocompetent patient.
Yumkham Monica DeviAmit SehrawatPrasan Kumar PandaUttam Kumar NathPublished in: BMJ case reports (2021)
While lymphopenia has been a common finding in COVID-19 infection, particularly in severe cases, febrile neutropenia has been very rarely reported in immunocompetent patients with COVID-19. Herein, we report the case of a 76-year-old hypertensive and diabetic man who was hospitalised with severe COVID-19 infection and developed delayed-onset severe neutropenia with neutropenic fever, which responded to treatment with antibiotics and granulocyte colony-stimulating factor. This case highlights the importance of identifying a rare complication (febrile neutropenia on the fifth week) of COVID-19 infection in hospitalised patients by intensive monitoring and aggressive management for favourable outcomes.
Keyphrases
- chemotherapy induced
- end stage renal disease
- early onset
- urinary tract infection
- coronavirus disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- sars cov
- blood pressure
- type diabetes
- prognostic factors
- peritoneal dialysis
- case report
- drug induced
- randomized controlled trial
- community acquired pneumonia
- peripheral blood
- adipose tissue
- study protocol
- wound healing